Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25987320 | 0.85 | ALDH1A1 (0.38) | LMNAMAPTALDH1A1MAPK1CYP3A4 | |
| SCHEMBL28700702 | 0.83 | KDM1A (0.46) | LMNASMN1; SMN2MAPTALDH1A1MAPK1 | |
| SCHEMBL1777917 | 0.83 | ALDH1A1 (0.43) | LMNASMN1; SMN2ALDH1A1MAPK1CYP3A4 | |
| SCHEMBL25953068 | 0.81 | ALDH1A1 (0.43) | LMNASMN1; SMN2MAPTALDH1A1MAPK1 | |
| SCHEMBL22110764 | 0.81 | LMNA (0.46) | LMNARXFP1SMN1; SMN2MAPTNCEH1 | |
| SCHEMBL4853806 | 0.79 | SMN1; SMN2 (0.45) | LMNARXFP1SMN1; SMN2MAPT | |
| SCHEMBL23089940 | 0.77 | ALDH1A1 (0.40) | LMNARXFP1MAPTALDH1A1MAPK1 | |
| SCHEMBL29368388 | 0.77 | ALDH1A1 (0.40) | LMNARXFP1MAPTALDH1A1MAPK1 | |
| SCHEMBL26345931 | 0.77 | LMNA (0.39) | LMNARXFP1SMN1; SMN2MAPTNCEH1 | |
| SCHEMBL29675074 | 0.76 | TSHR (0.46) | LMNARXFP1SMN1; SMN2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1660450-A4 | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2,7-DIFUNCTIONALIZED CARBAZOLES | UNIV LAVAL (CA) | 2009-07-29 | — | — | EP | claimed |
| US-20070069197-A1 | Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbzoles | UNIVERSITE LAVAL (CA) | 2007-03-29 | — | — | US | claimed |
| JP-2007502251-A | — | — | 2007-02-08 | — | — | JP | claimed |
| EP-1660450-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2,7-DIFUNCTIONALIZED CARBAZOLES | Université Laval (CA) | 2006-05-31 | — | — | EP | claimed |
| WO-2005016882-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2,7-DIFUNCTIONALIZED CARBAZOLES | UNIVERSITE LAVAL (CA) | 2005-02-24 | — | — | WO | claimed |
| EP-4239035-A2 | HIGH TRANSPARENCY ELECTROCHROMIC POLYMERS | Ambilight, Inc. (KY) | 2023-09-06 | — | — | EP | disclosed |
| US-20230250223-A1 | HIGH TRANSPARENCY ELECTROCHROMIC POLYMERS | AMBILIGHT INC. (KY) | 2023-08-10 | — | — | US | disclosed |
| US-20230250223-A1 | HIGH TRANSPARENCY ELECTROCHROMIC POLYMERS | AMBILIGHT INC. (KY) | 2023-08-10 | — | — | US | disclosed |
| EP-1660450-A4 | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2,7-DIFUNCTIONALIZED CARBAZOLES | UNIV LAVAL (CA) | 2009-07-29 | — | — | EP | disclosed |
| US-20070069197-A1 | Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbzoles | UNIVERSITE LAVAL (CA) | 2007-03-29 | — | — | US | disclosed |
| EP-1660450-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2,7-DIFUNCTIONALIZED CARBAZOLES | Université Laval (CA) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005016882-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2,7-DIFUNCTIONALIZED CARBAZOLES | UNIVERSITE LAVAL (CA) | 2005-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070069197-A1 | Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbzoles | TELO2, DNMT1, DDT | LMNA 3121/4885RXFP1 4360/4885SMN1; SMN2 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.